Moderate

Occupational asthma

work-related airways · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Occupational asthma is new-onset asthma caused by a workplace sensitiser (e.g. isocyanates, flour, latex) or irritant exposure. Early diagnosis and removal from exposure are critical because persistence worsens prognosis and symptoms may continue even after cessation.

Red flags

  • Severe exacerbation after workplace re-exposure
  • Progressive symptoms despite controller therapy
  • Co-workers similarly affected (points to a cluster)
  • Anaphylaxis to high-molecular-weight agent (e.g. latex)

Assessment

Differential diagnosis

  • Work-exacerbated pre-existing asthma
  • Irritant-induced asthma / reactive airways dysfunction syndrome
  • Hypersensitivity pneumonitis
  • Rhinitis without asthma
  • Building-related non-specific symptoms

Investigations

  • Detailed occupational and exposure history with timeline relative to symptoms
  • Serial peak expiratory flow monitoring at and away from work (>=4x/day, 3-4 weeks)
  • Spirometry with reversibility and non-specific bronchial challenge
  • Specific IgE / skin-prick testing to workplace allergen where available
  • Specific inhalation (bronchial provocation) challenge in a specialist centre (gold standard)
  • FeNO and blood eosinophils

Management

  • Take a structured occupational history linking symptoms to work and relief on holidays/weekends
  • Identify the specific agent and whether it is a sensitiser or irritant
  • Arrange serial PEF monitoring across work and rest periods and interpret with occupational tools
  • Confirm immunological sensitisation where a test exists
  • Refer to an occupational lung disease specialist for definitive testing
  • Remove the worker from exposure as early as possible once confirmed
  • Treat the asthma with standard inhaled controller therapy
  • Advise on redeployment, respiratory protection and workplace control measures
  • Report to the relevant occupational disease authority and support compensation claims
  • Monitor long term as airway responsiveness may persist despite exposure cessation

Drugs & doses

ICS-LABA e.g. beclometasone-formoterol 100/6 mcg 2 puffs twice daily
Salbutamol 100 mcg 2 puffs as reliever
Prednisolone 40 mg PO daily short course for exacerbations

Disposition

Occupational lung disease clinic; statutory reporting; workplace exposure control and potential redeployment.

Complications & pitfalls

  • Persistent asthma despite removal from exposure
  • Loss of employment and income
  • Fixed airflow obstruction
  • Progression to severe asthma

Exam pearls

  • Earlier removal from exposure gives the best chance of recovery
  • A normal challenge off-work does not exclude occupational asthma — test near exposure
  • Isocyanates (spray painting, polyurethane) are a leading cause
  • Latex and flour/enzyme exposures are classic high-molecular-weight causes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.